Filing Details
- Accession Number:
- 0001019687-15-001080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-24 19:00:03
- Reporting Period:
- 2015-03-23
- Filing Date:
- 2015-03-24
- Accepted Time:
- 2015-03-24 19:00:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1574235 | Ruthigen Inc. | RTGN | Pharmaceutical Preparations (2834) | 461821392 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1367083 | Oculus Innovative Sciences, Inc. | 1129 N. Mcdowell Blvd. Petaluma CA 94954 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value Per Share | Disposition | 2015-03-23 | 350,000 | $2.75 | 1,650,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Such sale is subject to the retention of voting rights by the reporting person as described in more detail in the Schedule 13D filed with the U.S. Securities and Exchange Commission on March 23, 2015.
- The reporting person is the former parent company of the issuer.
- Each of the directors, officers and stockholders of Oculus Innovative Sciences, Inc. expressly disclaims beneficial ownership of any shares of common stock, except to the extent of any pecuniary interest therein, and this Form 4 shall not be deemed an admission that any such person or entity is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purposes.
Billionaire Hedge Funds
